---
title: 'Manager, Study Start Up at Eikon Therapeutics'
canonical: 'https://feeny.ai/job/manager-study-start-up-eikon-therapeutics-jersey-city-sjbsvdttnvc6'
type: 'job'
last_seen: '2026-11-08'
---

# Manager, Study Start Up at Eikon Therapeutics

- **Company:** Eikon Therapeutics
- **Location:** Jersey City, NJ
- **Posted:** 2026-11-02
- **Last confirmed live:** 2026-11-08
- **Apply:** https://job-boards.greenhouse.io/eikontherapeutics/jobs/5280305007

## Job description

Eikon Therapeutics is a new biopharmaceutical company employing revolutionary technology at the intersection of chemistry, engineering, computation, and biology to discover novel treatments for life-threatening diseases. Eikon’s discovery platform is built on groundbreaking innovations from its founders (Nobel Prize, 2014), culminating in the creation of microscopes which enable real time, molecular-resolution measurements of protein movement in living cells, thereby unlocking otherwise intractable classes of proteins as drug targets.

Position

We are currently seeking an experienced, collaborative, detail oriented Manager, Study Start Up expert. In this role you will work with the Senior Director, Study Start Up and the clinical trial teams to improve operational excellence and efficiency of clinical trial execution in study and site start up across all phases of Clinical Development activities at Eikon Therapeutics by: Driving study feasibility deliverables and providing data driven recommendations to accelerate clinical trials and Supporting Clinical Development Operations Study Planning: to ensure proper planning and timely execution of all clinical trials in alignment with timelines and quality standards.

This role will require a minimum of 3 days a week of onsite presence (or more as business needs require) in our Jersey City (NJ) office to ensure effective management, operational excellence and high-performance delivery of clinical studies and to support the expected significant team growth & collaboration.

## About You

You are collaborative and passionate about unlocking hidden insights in today’s clinical operations landscape and relentless in your pursuit of operational excellence.

## What You’ll Do

- Working closely with Clinical Development R&D functions, enhance analytic capabilities to ensure the right questions are being asked and data is being leveraged to drive study feasibility deliverables and provide data driven recommendations to accelerate our clinical trials in study design and study start up.
- Engage and develop strong working relationships with clinical study teams (e.g., Clinical Operations, Clinical Supply, Legal, Regulatory, Clinical IT, Clinical R&D Process and Learning Management, Clinical Project and Portfolio Management, Clinical Quality Assurance, Clinical Data Management, and Clinical Research) to generate the best outcomes for study and site start up activities.
- Drive adherence to standards for planning and execution of study start up, country requirements, working in collaboration with Clinical Operations on site information management activities to ensure time critical and high-quality delivery of study specific needs.
- Partnering with Clinical Operations and clinical trial team, ensure the real time collection of information that informs country allocation, investigator site identification through activation, forecasting and planning and contributes to accurate site activation deliverables.
- Support the Clinical Operations team in the successful execution of clinical trials, from protocol concept to Site Activation, complying with ICH / GCP / EMEA guidelines and regulations and SOPs.
- Ensure that selected sites are meeting or exceeding all study start up requirements leading to Site Activation. This includes gathering and monitoring start up metrics to measure against KPIs.
- As required, develop site budgets & contracts, establish achievable finalization target dates and support the negotiations process leveraging FMV.
- Engage Legal and Finance as deemed necessary.
- Collect and summarize data and study start up insights for Clinical Operations and clinical trial team’s consideration to improve Study Start Up turn around times.
- Create, manage and archive central start up team tools (e.g., investigator database, clinical site intelligence, etc.) and resources required to support start up team daily operations, communications and records from study assignment to final handoff.
- Proactively identify and implement best study start up practices, seeking continuous process improvement.
- Facilitate study start up forum discussions.
- Support in the development of local workflows to streamline output and deliverables.
- Support Clinical Development Operations in driving a partnering mindset.

## Qualifications

- Post Graduate degree with 4+ years of experience or a Bachelor's degree with 6+ years of experience in a relevant field (e.g., life sciences, healthcare, or related discipline). Solid understanding of US and global regulations and guidelines (e.g., FDA, EMEA, ICH) applicable to clinical development.
- Significant experience within the pharmaceutical industry or clinical research organization (CRO) working with clinical data and clinical development processes.
- Deep understanding of complexities of study start up.
- Strong analytical and project management skills.
- Able to rapidly adapt to changes in the work environment, manage competing demands and change approach or method to achieve optimal fit-for-purpose solution.
- Excellence in driving results. You persist in accomplishing objectives and exceeding goals despite obstacles and setbacks, while also helping others to achieve results.
- Excellent verbal / written communication and collaboration skills and ability to influence and build effective relationships in a matrix organization, including to to ensure timely follow-up, issue resolution, and report updates.
- Experience with Veeva clinical solutions and familiarity with leveraging multiple technologies.

At Eikon, employee compensation also includes bonus and equity compensation, in addition to several generous benefit programs, including:​

- 401k plan with company matching​
- Medical (premiums covered by Eikon at 95%), dental and vision insurance (premiums covered by Eikon at 100%)​
- Mental health and wellness benefits​
- Weeklong summer and winter holiday shutdowns​
- Generous paid time off and holiday policies​
- Life/AD&D Insurance (premiums covered by Eikon at 100%) and optional supplemental employee-paid life/AD&D policies ​
- Enhanced parental leave benefit​
- Daily subsidized lunch program when on-site​

The expected salary range for this role is $130,000 to $157,500 depending on skills, competency, and the market demand for your expertise. Eikon is proud to be an equal opportunity employer and will consider all qualified applicants for employment.

We are currently not accepting any new third-party agencies or firms at this time. Please do not forward unsolicited agency resumes to our website, employees or Human Resources. Eikon Therapeutics will not pay fees to any third-party agency or firm associated with unsolicited resumes.

## About Eikon Therapeutics

## Company Overview
- **One-liner**: Eikon Therapeutics is a late-stage clinical biopharmaceutical company that integrates single-molecule imaging, machine learning, and engineering to discover and develop novel therapies for oncology, immunology, and neuroscience.
- **Entity Type**: Public (NASDAQ: EIKN) – originally privately held, went public via a post-IPO equity round in 2026.
- **Headquarters**: Millbrae, California, United States
- **Founded**: 2019
- **Founders**: Not publicly named in the search results; the company was seeded by The Column Group.

## Core Business
- **Primary industry**: Biotechnology research and drug development (therapeutics)
- **Target customers**: Patients with unmet medical needs; the company partners with clinical research organizations, healthcare providers, and regulators.
- **Mission or purpose statement**: “Better insights will lead to better medicines” – the company aims to introduce new therapies that improve and extend life by deeply understanding human disease biology.

## Products & Services
- **EIK10 (TLR7/8 agonist)**: Phase 2 clinical program for solid tumors, leveraging immune response modulation.
- **VCP inhibitor (undisclosed target)**: Phase 1 program in oncology.
- **AR-v7 degrader**: Preclinical/early clinical program targeting androgen receptor splice variant in cancer.
- **PARP1 inhibitor**: Early-stage oncology program; also a CNS-penetrant PARP1 candidate for neuroscience.
- **AR degrader**: Preclinical androgen receptor degrader.
- **Discovery-stage programs**: Multiple undisclosed targets in oncology, immunology, and neuroscience, supported by the company’s single-molecule imaging platform.

## Market Standing
- **Valuation/Market Cap**: Not disclosed in search results; total funding of ~$1.5B as of mid-2026.
- **Key Metrics**:
  - Annual Revenue: $5.6M (reflective of early-stage, pre-commercial biotech).
  - Total Funding: $1.5B (seed, Series A $148M in 2021, Series B $518M in 2022, Series C $106M in 2023, and post-IPO equity of $381.2M in 2026).
- **Notable Investors/Partners**: The Column Group (lead seed/Series A), 18 investors in Series B, and multiple institutional partners across rounds; board includes industry veterans (e.g., Roger Perlmutter, former Merck CEO).
- **Growth Signals**:
  - Headcount grew ~2.7% YoY to 314 employees (2025–2026).
  - Active job postings increased 270% year-over-year (as of mid-2026).
  - Expanding pipeline into immunology and neuroscience beyond oncology.
  - Recent $351M financing event (reported by multiple outlets) to fund late-stage trials.

## Competitive Advantages
- **Proprietary single-molecule imaging platform** that enables real-time observation of protein dynamics at the single-molecule level, providing insights into disease mechanisms that traditional methods miss.
- **Machine learning integration** to analyze massive imaging datasets, accelerating target identification and drug design.
- **Deep bench of scientific talent**: Executives include Roger Perlmutter (CEO, ex-Merck), Roy Baynes (CMO, ex-Merck), and a team drawing from Genentech, Bristol Myers Squibb, Pfizer, and top academic institutions.
- **Cross-disciplinary approach** merging biology, engineering, and computation under one roof, reducing the “translation gap” between discovery and clinic.

## Strategic Focus
- **Advancing late-stage oncology pipeline**: Lead program (TLR7/8 agonist) in Phase 2, with plans to move into pivotal trials.
- **Expanding into new therapeutic areas**: Significant preclinical investment in immunology and neuroscience, with CNS-penetrant PARP1 and AR programs.
- **Continued platform development**: Scaling imaging and machine learning capabilities to enable faster, more precise drug discovery across multiple indications.
- **Building commercial infrastructure**: Post-IPO financing supports preparation for potential product launches and expanded clinical operations.

## Why Work Here
- **Culture**: Values-driven environment prioritizing execution, collaboration, innovation, transparency, respect, and caring for patients and colleagues.
- **Engineering & science fusion**: Opportunity to work at the intersection of advanced imaging, machine learning, and drug development – unique in biotech.
- **Growth trajectory**: Young company with strong funding, public listing, and rapidly expanding pipeline; employees can have significant impact.
- **Compensation**: Competitive base salaries (e.g., Software Engineer ~$140k, Senior Software Engineer ~$167k) plus equity incentives.
- **Work model**: Likely office-based at the Millbrae HQ or satellite labs in Hayward, CA; clinical roles may require travel; no explicit remote/hybrid policy in search results.
- **Perks**: Not detailed, but typical biotech benefits (health, 401k, PTO) are assumed; the company emphasizes a “transparent and inclusive culture” per its values.
- **Employee sentiment**: Overall rating 3.0/5 on LinkedIn (66 reviews); work-life balance 3.2, compensation 3.4, culture 3.0, career opportunities 2.9 – indicating room for improvement in career development.

## Sources
1. [eikontx.com](https://www.eikontx.com/)
2. [eikontx.com/about-us](https://www.eikontx.com/about-us/)
3. [eikontx.com/join-us](https://www.eikontx.com/join-us/)
4. [eikontx.com/pipeline](https://www.eikontx.com/pipeline/)
5. [linkedin.com/company/eikon-therapeutics-inc](https://www.linkedin.com/company/eikon-therapeutics-inc)

## Other roles at Eikon Therapeutics

- [Scientist I, High-Throughput Biology](https://feeny.ai/job/scientist-i-high-throughput-biology-eikon-therapeutics-millbrae-m74ftqevc49h) — Millbrae, CA
- [Director, Site Engagement & Monitoring Excellence (CONTRACT)](https://feeny.ai/job/director-site-engagement-monitoring-excellence-contract-eikon-therapeutics-mq2a3tcremrq) — Jersey City, NJ / Millbrae, CA
- [Clinical Trial Associate, APAC (CONTRACT)](https://feeny.ai/job/clinical-trial-associate-apac-contract-eikon-therapeutics-jersey-city-q6jkqzeyd2k2) — Jersey City, NJ / Millbrae, CA
- [Lab Operations Supervisor](https://feeny.ai/job/lab-operations-supervisor-eikon-therapeutics-millbrae-x3vbjdmv2xtb) — Millbrae, CA
- [Senior Scientist I, Cheminformatics](https://feeny.ai/job/senior-scientist-i-cheminformatics-eikon-therapeutics-millbrae-2m0m09mnsw8c) — Millbrae, CA
- [Senior Manager, Pharmacovigilance](https://feeny.ai/job/senior-manager-pharmacovigilance-eikon-therapeutics-jersey-city-85a1kxt3zerr) — Jersey City, NJ
- [Clinical Quality Operations Manager](https://feeny.ai/job/clinical-quality-operations-manager-eikon-therapeutics-millbrae-0mczwgq31knh) — Millbrae, CA / Jersey City, NJ
- [Senior Director, Translational Medicine](https://feeny.ai/job/senior-director-translational-medicine-eikon-therapeutics-jersey-city-1697yzqsxsjb) — Jersey City, NJ / Millbrae, CA
- [Associate Director, Clinical Data Management](https://feeny.ai/job/associate-director-clinical-data-management-eikon-therapeutics-jersey-city-6rkwk4ya8pa0) — Jersey City, NJ / Millbrae, CA
- [Scientist, Computational Biology](https://feeny.ai/job/scientist-computational-biology-eikon-therapeutics-millbrae-feqcsff97ncf) — Millbrae, CA